A new advanced artificial intelligence (AI) algorithm may lead to better—and earlier—predictions and novel therapies for autoimmune diseases, which involve the immune system mistakenly ...

Alphabiome's proprietary algorithm analyzed trillions of genetic data points and identified over 10,000 complex microbe-derived biomarkers related to the successful use of these drugs.

Researchers suggest the DeepRVAT model is the first to use artificial intelligence (AI) in genomic association studies to decipher rare genetic variants.

Despite the hype over artificial intelligence in medicine, the systems require consistent monitoring and staffing to put in place and maintain.